Ryan Dellinger is vice president of scientific affairs at Elysium Health, where he works on product development, intellectual property, scientific collaborations, and clinical trials. Previously, Ryan was director of scientific affairs at another dietary supplement and ingredient company. Prior to that, he was an assistant project scientist at the University of California, Irvine, where he was involved in several pre-clinical and clinical studies investigating skin cancer prevention.
Ryan also served as a postdoctoral researcher in the pharmacology department at Penn State University Medical Center, where he spent four years investigating the mechanism of activity of Phase II metabolic enzymes and their role in cancer risk, treatment, and prevention. Ryan holds a B.S. in biochemistry from the University of the Pacific and a Ph.D. in biochemistry and molecular biology from the University of California, San Diego.